Chris Nelson is focused on the digital transformation of diagnostics and therapeutics. His work spans from the bench to the clinic, including a blood typing test adopted by the UK NHS and building the bifx pipeline for the state-of-the-art liquid biopsy assay, NeXT Personal. Currently, he is spearheading a venture in mRNA AI optimization, utilizing intelligent design to refine genetic medicine. Chris is passionate about the synergy between AI-driven discovery and clinical scalability, seeking to de-risk the path from lab to patient. His mission is to build robust, intelligent platforms that accelerate the delivery of life-saving biological technologies.